Cargando…

Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study

Data on residual clinical damage after Coronavirus disease-2019 (COVID-19) are lacking. The aims of this study were to investigate whether COVID-19 leaves behind residual dysfunction, and identify patients who might benefit from post-discharge monitoring. All patients aged ≥18 years admitted to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Lorenzo, Rebecca, Conte, Caterina, Lanzani, Chiara, Benedetti, Francesco, Roveri, Luisa, Mazza, Mario G., Brioni, Elena, Giacalone, Giacomo, Canti, Valentina, Sofia, Valentina, D’Amico, Marta, Di Napoli, Davide, Ambrosio, Alberto, Scarpellini, Paolo, Castagna, Antonella, Landoni, Giovanni, Zangrillo, Alberto, Bosi, Emanuele, Tresoldi, Moreno, Ciceri, Fabio, Rovere-Querini, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556454/ https://www.ncbi.nlm.nih.gov/pubmed/33052920 http://dx.doi.org/10.1371/journal.pone.0239570

Ejemplares similares

Post-COVID-19 follow-up clinic: depicting chronicity of a new disease
por: Rovere-Querini, Patrizia, et al.
Publicado: (2020)

COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: A post-hoc analysis of a prospective cohort study
por: Di Filippo, Luigi, et al.
Publicado: (2021)

Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study
por: Conte, Caterina, et al.
Publicado: (2021)

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
por: Ripa, Marco, et al.
Publicado: (2021)

Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19
por: Di Filippo, Luigi, et al.
Publicado: (2020)

Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy
por: Ciceri, Fabio, et al.
Publicado: (2020)

Pulmonary Vascular Thrombosis in COVID-19 Pneumonia
por: De Cobelli, Francesco, et al.
Publicado: (2021)

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
por: Cavalli, Giulio, et al.
Publicado: (2021)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
por: Spagnuolo, V., et al.
Publicado: (2021)

Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
por: Spagnuolo, V., et al.
Publicado: (2020)

Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification
por: Bravi, Carlo Andrea, et al.
Publicado: (2022)

Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis
por: Ciceri, Fabio, et al.
Publicado: (2023)

Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients
por: Mushtaq, Junaid, et al.
Publicado: (2020)

Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
por: Benedetti, Francesco, et al.
Publicado: (2020)

The 5 Reasons Why People Die of Coronavirus Disease 2019
por: Marmiere, Marilena, et al.
Publicado: (2021)

505. Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2021)

Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
por: Spagnuolo, Vincenzo, et al.
Publicado: (2022)

Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection
por: Lanzani, Chiara, et al.
Publicado: (2021)

QTc interval prolongation, inflammation, and mortality in patients with COVID-19
por: Gulletta, Simone, et al.
Publicado: (2021)

Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
por: Benedetti, Francesco, et al.
Publicado: (2021)

Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
por: Zangrillo, Alberto, et al.
Publicado: (2023)

Combined plasma levels of IL‐10 and testosterone, but not soluble HLA‐G5, predict the risk of death in COVID‐19 patients
por: Amodio, Giada, et al.
Publicado: (2022)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Stranger Months: How SARS-CoV-2, Fear of Contagion, and Lockdown Measures Impacted Attendance and Clinical Activity During February and March 2020 at an Urban Emergency Department in Milan
por: Franchini, Stefano, et al.
Publicado: (2020)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

Association of genetic variants in the 3′UTR of HLA-G with Recurrent Pregnancy Loss
por: Amodio, Giada, et al.
Publicado: (2016)

High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19
por: Ripa, Marco, et al.
Publicado: (2022)

Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder
por: Benedetti, Francesco, et al.
Publicado: (2022)

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors
por: Mazza, Mario Gennaro, et al.
Publicado: (2020)

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
por: De Luca, Giacomo, et al.
Publicado: (2020)

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
por: Cavalli, Giulio, et al.
Publicado: (2020)

Trimethoprim-sulfamethoxazole induced aseptic meningitis case report
por: Pata, Giulia, et al.
Publicado: (2023)

Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life
por: Poletti, Sara, et al.
Publicado: (2021)

Recent exposure to smoking and COVID-19
por: Landoni, Giovanni, et al.
Publicado: (2023)

COVID-19 seasonality in temperate countries
por: D'Amico, Filippo, et al.
Publicado: (2022)

Association between Perceived Health-Related Quality of Life and Depression with Frailty in the FRASNET Study
por: Delli Zotti, Giulia B., et al.
Publicado: (2022)

Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up
por: Mazza, Mario Gennaro, et al.
Publicado: (2021)

One-year mental health outcomes in a cohort of COVID-19 survivors
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)

Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report
por: Rovere-Querini, Patrizia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_orhl050rv4q8hu1g666vl1id09